BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 25960196)

  • 1. Type I interferon and T helper 17 cells co-exist and co-regulate disease pathogenesis in lupus patients.
    Biswas PS; Aggarwal R; Levesque MC; Maers K; Ramani K
    Int J Rheum Dis; 2015 Jul; 18(6):646-53. PubMed ID: 25960196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
    Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
    Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of T helper 17 cells in the pathogenesis of systemic lupus erythematosus.
    Abou Ghanima AT; Elolemy GG; Ganeb SS; Abo Elazem AA; Abdelgawad ER
    Egypt J Immunol; 2012; 19(2):25-33. PubMed ID: 23885404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE).
    Oke V; Brauner S; Larsson A; Gustafsson J; Zickert A; Gunnarsson I; Svenungsson E
    Arthritis Res Ther; 2017 Jun; 19(1):139. PubMed ID: 28619037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus.
    Yang XY; Wang HY; Zhao XY; Wang LJ; Lv QH; Wang QQ
    J Clin Immunol; 2013 May; 33(4):767-74. PubMed ID: 23435610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MIF promotes a differential Th1/Th2/Th17 inflammatory response in human primary cell cultures: Predominance of Th17 cytokine profile in PBMC from healthy subjects and increase of IL-6 and TNF-α in PBMC from active SLE patients.
    De la Cruz-Mosso U; García-Iglesias T; Bucala R; Estrada-García I; González-López L; Cerpa-Cruz S; Parra-Rojas I; Gámez-Nava JI; Pérez-Guerrero EE; Muñoz-Valle JF
    Cell Immunol; 2018 Feb; 324():42-49. PubMed ID: 29397904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Th-17 related regulatory network in the pathogenesis of Arab patients with systemic lupus erythematosus and lupus nephritis.
    AlFadhli S; AlFailakawi A; Ghanem AA
    Int J Rheum Dis; 2016 May; 19(5):512-20. PubMed ID: 25496163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased plasma IL-22 levels and correlations with IL-22-producing T helper cells in patients with new-onset systemic lupus erythematosus.
    Lin J; Yue LH; Chen WQ
    Scand J Immunol; 2014 Feb; 79(2):131-6. PubMed ID: 24313261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arthritis in systemic lupus erythematosus is characterized by local IL-17A and IL-6 expression in synovial fluid.
    Sippl N; Faustini F; Rönnelid J; Turcinov S; Chemin K; Gunnarsson I; Malmström V
    Clin Exp Immunol; 2021 Jul; 205(1):44-52. PubMed ID: 33576004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum free light chains, interferon-alpha, and interleukins in systemic lupus erythematosus.
    Jolly M; Francis S; Aggarwal R; Mikolaitis RA; Niewold TB; Chubinskaya S; Block JA; Scanzello C; Sequeira W
    Lupus; 2014 Aug; 23(9):881-8. PubMed ID: 24786785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of 1 Alpha, 25-Dihydroxyvitamin D3 on T Helper 17 Cells and Related Cytokines in Systemic Lupus Erythematosus.
    Reihani H; Rastin M; Mahmoudi M; Ghoryani M; Abdollahi N; Tabasi NS; Zamani Taghizadeh Rabe S; Sahebari M
    Iran J Immunol; 2015 Jun; 12(2):82-93. PubMed ID: 26119191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential.
    Zhou Z; Tian Z; Zhang M; Zhang Y; Ni B; Hao F
    Immunol Invest; 2018 Jul; 47(5):468-483. PubMed ID: 29611775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and significance of Th17 and Treg cells in peripheral blood of patients with systemic lupus erythematosus].
    Cai XY; Luo M; Lin XJ; Xu YL; Tang C; Ye JH; Li WN; He ZX; Yu N
    Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(7):460-3. PubMed ID: 22490966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity.
    Robak E; Sysa-Jedrzejewska A; Dziankowska B; Torzecka D; Chojnowski K; Robak T
    Arch Immunol Ther Exp (Warsz); 1998; 46(6):375-80. PubMed ID: 9883317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus.
    Shah K; Lee WW; Lee SH; Kim SH; Kang SW; Craft J; Kang I
    Arthritis Res Ther; 2010; 12(2):R53. PubMed ID: 20334681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosus.
    Dolff S; Bijl M; Huitema MG; Limburg PC; Kallenberg CG; Abdulahad WH
    Clin Immunol; 2011 Nov; 141(2):197-204. PubMed ID: 21920821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-alpha and interleukin-6 in SLE serum induce the differentiation and maturation of dendritic cells derived from CD34+ hematopoietic precursor cells.
    Zhang R; Xing M; Ji X; Gu L; Yang X; Wang H; Jiang P
    Cytokine; 2010 May; 50(2):195-203. PubMed ID: 20303780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus.
    Lit LC; Wong CK; Li EK; Tam LS; Lam CW; Lo YM
    J Rheumatol; 2007 Jan; 34(1):89-96. PubMed ID: 17117487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE.
    Rozo C; Chinenov Y; Maharaj RK; Gupta S; Leuenberger L; Kirou KA; Bykerk VP; Goodman SM; Salmon JE; Pernis AB
    Ann Rheum Dis; 2017 Apr; 76(4):740-747. PubMed ID: 28283529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential role of interferon-regulatory factor 7 among Taiwanese patients with systemic lupus erythematosus.
    Lin LH; Ling P; Liu MF
    J Rheumatol; 2011 Sep; 38(9):1914-9. PubMed ID: 21632682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.